Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor α alters estrogen-responsive gene expression

Cancer Research

Volumn 67, Issue 21, 2007, Pages 10600-10607

  Curtis, Carol D ^a   Likhite, Varsha S ^b   McLeod, Ian X ^c   Yates, John R ^c   Nardulli, Ann M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; NUCLEOSIDE DIPHOSPHATE KINASE A; PROGESTERONE RECEPTOR; PROTEIN BCL 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DNA REPAIR; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; IMMUNOPRECIPITATION; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PLASMIDS; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 35948976905     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0055     Document Type: Article

References (50)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics. CA Cancer J Clin 2005;55:10-30.
2. Horak CE, Steeg PS. Metastasis gets site specific. Cancer Cell 2005;8:93-5.
3. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904.
4. Zheng WQ, Lu J, Zheng JM, Hu FX, Ni CR. Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression. Steroids 2001;66:905-10.
5. Keen JC, Davidson NE. The biology of breast carcinoma. Cancer 2003;97:825-33.
6. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999;20:358-417.
7. Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-65.
8. Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 2003;17:1681-92.
9. Smith C, Nawaz Z, O'Malley B. Coactivator and corepressor regulation of agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 1997;11:657-66.
10. Chien PY, Ito M, Park Y, Tagami T, Gehm BD, Jameson JL. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. Mol Endocrinol 1999;13:2122-36.
11. Allan G, Leng X, Tsai N, Edwards D, Tsai M-J, O'Malley B. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem 1992;267:19513-20.
12. Hall JM, McDonnell DP, Korach KS. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol Endocrinol 2002;16:469-86.
13. Wood JR, Likhite VS, Loven MA, Nardulli AM. Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol Endocrinol 2001;15:1114-26.
14. Loven MA, Muster N, Yates JR, Nardulli AM. A novel estrogen receptor α associated protein, template activating factor Iβ, inhibits acetylation and transactivation. Mol Endocrinol 2003;17:67-78.
15. Loven MA, Davis RE, Curtis CD, Muster N, Yates JR, Nardulli AM. A novel estrogen receptor α-associated protein alters receptor-deoxyribonucleic acid interactions and represses receptor-mediated transcription. Mol Endocrinol 2004;18:2649-59.
16. Rosengard AM, Krutzsch HC, Shearn A, et al. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 1989;342:177-80.
17. Hartsough MT, Steeg PS. Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 2000;32:301-8.
18. Hartsough MT, Morrison DK, Salerno M, et al. Nm23-1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 2002;277:32389-99.
19. Yoon JH, Singh P, Lee DH, et al. Characterization of the 3′ → 5′ exonuclease activity found in human nucleoside diphosphate kinase 1 (NDK1) and several of its homologues. Biochemistry 2005;44:15774-86.
20. Chowdhury D, Beresford PJ, Zhu P, et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 2006;23:133-42.
21. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J. Tumor suppressor NM23-1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003;112:659-72.
22. Schultz-Norton JR, Walt KA, Ziegler YS, et al. The DNA repair protein Flap endonuclease-1 (FEN-1) modulates estrogen-responsive gene expression. Mol Endocrinol 2007;21:1569-80.
23. Henttu PMA, Kalkhoven E, Parker MG. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol 1997;17:1832-9.
24. Chaidarun SS, Swearingen B, Alexander JM. Differential expression of estrogen receptor-β (ERβ) in human pituitary tumors: functional interactions with ERα and a tumor-specific splice variant. J Clin Endocrinol Metab 1998;83:3308-15.
25. Lin KH, Wang WJ, Wu YH, Cheng SY. Activation of antimetastatic Nm23-1 gene expression by estrogen and its α-receptor. Endocrinology 2002;143:467-75.
26. Landel CC, Kushner PJ, Greene GL. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol Endocrinol 1994;8:1407-19.
27. Boonyaratanakornkit V, Melvin V, Prendergast P, et al. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol 1998;18:4471-87.
28. Romine L, Wood J, Lamia L, Prendergast P, Edwards D, Nardulli A. The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol Endocrinol 1998;12:664-74.
29. Likhite VS, Cass EI, Anderson SD, Yates JR, Nardulli AM. Interaction of estrogen receptor α with 3-methyladenine DNA glycosylase modulates transcription and DNA repair. J Biol Chem 2004;279:16875-82.
30. Nardulli AM, Greene GL, O'Malley BW, Katzenellenbogen BS. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 1988;122:935-44.
31. Gompel A, Somai S, Chaouat M, et al. Hormonal regulation of apoptosis in breast cells and tissues. Steroids 2000;65:593-8.
32. Westley BR, May FE. Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res 1987;15:3773-86.
33. Altucci L, Addeo R, Cicatiello L, et al. 17β-Estradiol induces cyclin D1 gene transcription, p36D1-34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 1996;12:2315-24.
34. Kim J, Petz LN, Ziegler YS, Wood JR, Potthoff SJ, Nardulli AM. Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 2000;74:157-68.
35. Wang DY, Fulthorpe R, Liss SN, Edwards EA. Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol Endocrinol 2004;18:402-11.
36. Ouatas T, Salerno M, Palmieri D, Steeg PS. Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr 2003;35:73-9.
37. Petz LN, Ziegler YS, Loven MA, Nardulli AM. Estrogen receptor a and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Endocrinology 2002;143:4583-91.
38. Seo SB, McNamara P, Heo S, Turner A, Lane WS, Chakravarti D. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 2001;104:119-30.
39. Verrier CS, Roodi N, Yee CJ, et al. High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAFII30 affect estrogen receptor-mediated transcriptional activation. Mol Endocrinol 1997;11:1009-19.
40. Zhang CC, Krieg S, Shapiro DJ. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol Endocrinol 1999;13:632-43.
41. Oñate SA, Prendergast P, Wagner JP, et al. The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol 1994;14:3376-91.
42. Teo AK, Oh HK, Ali RB, Li BF. The modified human DNA repair enzyme O(6)-methylguanine-DNA methyltransferase is a negative regulator of estrogen receptor-mediated transcription upon alkylation DNA damage. Mol Cell Biol 2001;21:7105-14.
43. Morrison AJ, Shen X. Chromatin modifications in DNA repair. Results Probl Cell Differ 2006;41:109-25.
44. de Boer J, Andressoo JO, de Wit J, et al. Premature aging in mice deficient in DNA repair and transcription. Science 2002;296:1276-9.
45. Berardi P, Russell M, El-Osta A, Riabowol K. Functional links between transcription, DNA repair and apoptosis. Cell Mol Life Sci 2004;61:2173-80.
46. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H. Reduced expression of nm23-1, but not of nm23-2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer 1993;55:66-71.
47. Rochefort H, Capony F, Garcia M. Cathepsin D: a protease involved in breast cancer metastasis. Cancer Metastasis Rev 1990;9:321-31.
48. Charpin C, Garcia S, Bouvier C, et al. Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival. J Clin Pathol 1997;50:586-90.
49. Del Bufalo D, Biroccio A, Leonetti C, Zupi G. Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J 1997;11:947-53.
50. Biroccio A, Candiloro A, Mottolese M, et al. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. FASEB J 2000;14:652-60.